Oxidative Stress in Pediatric Patients with Acute Lymphoblastic Leukemia

Article Sidebar

PDF
Published: Sep 25, 2009
Keywords:
Oxidative stress Acute lymphoblastic leukemia Pediatric patients Cancer Antioxidant

Main Article Content

Phanphen Phoonlapdacha
Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Nalinee Chongviriyaphan
Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Abstract

Oxidative stress is associated with cancers via many mechanisms including lipid peroxidation and DNA damage. The interest in research on the role of free radicals in cancer pathogenesis is increasing. Acute lymphoblastic leukemia (ALL), the most common childhood cancer, is the primary cause of cancer-related mortality in children. Many components given to treat leukemia are associated with free radical production. In addition, the properties of antioxidant compounds for protection and alleviation of side effects of chemotherapy have been reported. However, there are a few reports on oxidative stress and antioxidant status in children with ALL. Therefore, we reviewed this topic for scientific knowledge and future research.

Article Details

How to Cite
1.
Phoonlapdacha P, Chongviriyaphan N. Oxidative Stress in Pediatric Patients with Acute Lymphoblastic Leukemia. Rama Med J [Internet]. 2009 Sep. 25 [cited 2024 Apr. 20];32(3):143-52. Available from: https://he02.tci-thaijo.org/index.php/ramajournal/article/view/175400
Issue
Vol. 32 No. 3 (2009): July-September
Section
Review Articles

References

Thannickal VJ, Fanbury BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000:279(6):L1005-28.

Haddad JJ. Redox and oxidant-mediated regulation of apoptosis signaling pathways: immuno-pharmaco-redox conception of oxidative siege versus cell death commitment. Int Immunopharmacol. 2004;4(4):475-493. doi:10.1016/j.intimp.2004.02.002.

Carmody RJ, Cotter TG. Signalling apoptosis: a radical approach. Redox Rep. 2001;6(2):77-90. doi:10.1179/135100001101536085.

Aslan M, Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid Redox Signal. 2003;5(6):781-788. doi:10.1089/152308603770380089.

Devi GS, Prasad MH, Saraswathi I, Raghu D, Rao DN, Reddy PP. Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin Chim Acta. 2000;293(1-2):53-62. doi:10.1016/s0009-8981(99)00222-3.

Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, et al. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med (Berl). 2003;81(10):664-673. doi:10.1007/s00109-003-0476-1.

Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004;7(2):97-110. doi:10.1016/j.drup.2004.01.004.

Hileman EO, Liu J, Albitar M, Keating MJ, Huang P. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol. 2004;53(3):209-219. doi:10.1007/s00280-003-0726-5.

Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood. 2003;101(10):4098-4104. doi:10.1182/blood-2002-08-2512.

Shacter E, Williams JA, Hinson RM, Sentürker S, Lee YJ. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood. 2000;96(1):307-313.

Park SY, Chang I, Kim JY, Kang SW, Park SH, Singh K, et al. Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase. J Biol Chem. 2004;279(9):7512-7520. doi:10.1074/jbc.M307677200.

Aydin A, Arsova-Sarafinovska Z, Sayal A, Eken A, Erdem O, Erten K, et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem. 2006;39(2):176-179. doi:10.1016/j.clinbiochem.2005.11.018.

Halliwall B, Gutteridge JMC. Free radicals In Biology and Medicine. 3rd ed. Oxford Clarendon: Oxford University Press; 1999.

Slater TF. Free-radical mechanisms in tissue injury. Biochem J. 1984;222(1):1-15. doi:10.1042/bj2220001.

Dizdaroglu M. Oxidative stress/DNA damage and DNA repair. DNA measurements Online: National Institute of Standards and Technology [online]. USA; 2005. Available from: http://www.cstl.nist.gov/div831/DNATechologies/DNA_Damage_repair.html. Accessed June 15, 2007.

Kaur H, Halliwell B. Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection. Biochem J. 1996;318 ( Pt 1)(Pt 1):21-23. doi:10.1042/bj3180021.

Holmberg I, Stål P, Hamberg M. Quantitative determination of 8-hydroxy-2'-deoxyguanosine in human urine by isotope dilution mass spectrometry: normal levels in hemochromatosis. Free Radic Biol Med. 1999;26(1-2):129-135. doi:10.1016/s0891-5849(98)00181-6.

Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now?. J Lab Clin Med. 1992;119(6):598-620.

Montgomery R, Conway TW, Spector AA, Chappell D. Biochemistry: A Case-Oriented Approach. 6th ed. St Louis MO: Mosby; 1996.

Bunker VW. Free radicals, antioxidants and ageing. Med Lab Sci. 1992;49(4):299-312.

Dizdaroglu M. Formation of an 8-hydroxyguanine moiety in deoxyribonucleic acid on gamma-irradiation in aqueous solution. Biochemistry. 1985;24(16):4476-4481. doi:10.1021/bi00337a032.

Halliwell B. Free radicals and antioxidants: a personal view. Nutr Rev. 1994;52(8 Pt 1):253-265. doi:10.1111/j.1753-4887.1994.tb01453.x.

Marks DB, Marks AD, Smith CM. Basic Medicine Biochemistry: A Clinical Approach. Baltimore, MD: William & Wilkins; 1996.

Rice-Evans CA, Burdon RH. Free Radical Damage and its Control. Amsterdam, New York: Elsevier; 1994.

Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper's Biochemistry. 24th ed. Stamford, CT: Appleton & Lange; 1996.

Ji LL. Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med. 1999;222(3):283-292. doi:10.1046/j.1525-1373.1999.d01-145.x.

Stryer L. Biochemistry. 3rd ed. New York, NY: W.H. Freeman;1988:592-3.

Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods. 3rd ed. Orlando, FL: Grune & Stratton;1984:89-90.

Burton GW, Ingold KU. Vitamin E as an in vitro and in vivo antioxidant. Ann N Y Acad Sci. 1989;570:7-22. doi:10.1111/j.1749-6632.1989.tb14904.x.

Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 2000;47(3):446-456. doi:10.1016/s0008-6363(00)00078-x.

White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(10):769-774.

Rice-Evans CA, Burdon RH. Free Radical Damage and its Control. Amsterdam, New York: Elsevier; 1994.

Rock CL, Jacob RA, Bowen PE. Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J Am Diet Assoc. 1996;96(7):693-704. doi:10.1016/S0002-8223(96)00190-3.

Bendich A, Machlin LJ, Scandurra O, Burton GW, Wayner DDM. The antioxidant role of vitamin C. Adv Free Radical Biol Med. 1986;2(2):419-444. doi:10.1016/S8755-9668(86)80021-7.

Block G. Vitamin C status and cancer. Epidemiologic evidence of reduced risk. Ann N Y Acad Sci. 1992;669:280-292. doi:10.1111/j.1749-6632.1992.tb17107.x.

Olinski R, Zastawny T, Budzbon J, Skokowski J, Zegarski W, Dizdaroglu M. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett. 1992;309(2):193-198. doi:10.1016/0014-5793(92)81093-2.

Jaruga P, Zastawny TH, Skokowski J, Dizdaroglu M, Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett. 1994;341(1):59-64. doi:10.1016/0014-5793(94)80240-8.

Pongrapeeporn K, Likidlilid A, Tirawanchai N, Ong-aj-yooth S, Kanluan T, Piankijagum A. Antioxidants State and Oxidative Stress with Tissue Damage in Leukemia. Bangkok: Faculty of Medicine Siriraj Hospita, Mahidol University; 1997.

Singh V, Ghalaut PS, Kharb S, Singh GP. Plasma concentrations of lipid peroxidation products in children with acute leukaemia. Indian J Med Sci. 2001;55(4):215-217.

Brown RE, Alade SL, Wu MC, Wu FM, Bowman WP. Lipoperoxidation and T-cell leukemia of childhood. Effects of indomethacin. Cancer. 1989;64(10):2090-2095. doi:10.1002/1097-0142(19891115)64:10<2090::aid-cncr2820641020>3.0.co;2-z.

Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk Res. 2000;24(6):461-468. doi:10.1016/s0145-2126(00)00006-0.

Yamanaka N, Nishida K, Ota K. Increase of superoxide dismutase activity in various human leukemia cells. Physiol Chem Phys. 1979;11(3):253-256.

Sentürker S, Karahalil B, Inal M, Yilmaz H, Müslümanoglu H, Gedikoglu G, et al. Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia. FEBS Lett. 1997;416(3):286-290. doi:10.1016/s0014-5793(97)01226-x.

Kennedy DD, Ladas EJ, Rheingold SR, Blumberg J, Kelly KM. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer. 2005;44(4):378-385. doi:10.1002/pbc.20307.

Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer. 2004;40(11):1713-1723. doi:10.1016/j.ejca.2004.02.029.

Kennedy M, Bruninga K, Mutlu EA, Losurdo J, Choudhary S, Keshavarzian A. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol. 2001;96(4):1080-1084. doi:10.1111/j.1572-0241.2001.03742.x.